Literature DB >> 15686610

Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance.

Johannes C Rothlind1, Tanya M Greenfield, Anne V Bruce, Dieter J Meyerhoff, Derek L Flenniken, Joselyn A Lindgren, Michael W Weiner.   

Abstract

Higher rates of alcohol use have been reported in HIV+ individuals compared to the general population. Both heavy alcohol use and HIV infection are associated with increased risk of neuropsychological (NP) impairment. We examined effects of heavy active alcohol use and HIV on NP functioning in a large sample of community-residing HIV+ individuals and HIV- controls. The four main study groups included 72 HIV- light/non-drinkers, 70 HIV- heavy drinkers (>100 drinks per month), 70 HIV+ light/non-drinkers, and 56 HIV+ heavy drinkers. The heavy drinking group was further subdivided to assess effects of the heaviest levels of active alcohol use (>6 drinks per day) on NP functioning. A comprehensive NP battery was administered. Multivariate analysis of covariance was employed to examine the effect of HIV and alcohol on NP functioning after adjusting for group differences in age and estimated premorbid verbal intellectual functioning. The analyses identified main effects of heavy drinking and HIV on NP function, with greatest effects involving the contrast of HIV+ heavy drinkers and the HIV- light drinkers. Synergistic effects of heaviest current drinking and HIV infection were identified in analyses of motor and visuomotor speed. Supplementary analyses also revealed better NP function in the HIV+ group with antiretroviral treatment (ART) and lower level of viral burden, a finding that was consistent across levels of alcohol consumption. Finally, heavy alcohol use and executive functioning difficulties were associated with lower levels of self-reported medication adherence in the HIV+ group. The findings suggest that active heavy alcohol use and HIV infection have additive adverse effects on NP function, that they may show synergistic effects in circumstances of very heavy active alcohol use, and that heavy drinking and executive functioning may mediate health-related behaviors in HIV disease.

Entities:  

Mesh:

Year:  2005        PMID: 15686610      PMCID: PMC2376753          DOI: 10.1017/S1355617705050095

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  67 in total

1.  Sexual orientation related differences in spatial memory.

Authors:  Qazi Rahman; Glenn D Wilson; Sharon Abrahams
Journal:  J Int Neuropsychol Soc       Date:  2003-03       Impact factor: 2.892

Review 2.  Neurocognitive aspects of medication adherence in HIV infection.

Authors:  Ola A Selnes
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

3.  A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.

Authors:  Andrea A Howard; Julia H Arnsten; Yungtai Lo; David Vlahov; Josiah D Rich; Paula Schuman; Valerie E Stone; Dawn K Smith; Ellie E Schoenbaum
Journal:  AIDS       Date:  2002-11-08       Impact factor: 4.177

Review 4.  Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology.

Authors:  Adolf Pfefferbaum; Margaret Rosenbloom; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2002-07       Impact factor: 3.455

5.  Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users.

Authors:  Arthur Margolin; S Kelly Avants; Lara A Warburton; Keith A Hawkins
Journal:  AIDS Patient Care STDS       Date:  2002-06       Impact factor: 5.078

6.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

7.  Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

Authors:  Ronald J Ellis; David J Moore; Meredith E Childers; Scott Letendre; J Allen McCutchan; Tanya Wolfson; Stephen A Spector; Karen Hsia; Robert K Heaton; Igor Grant
Journal:  Arch Neurol       Date:  2002-06

Review 8.  Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

Authors:  Fabrizio Starace; Adriana Ammassari; Maria Paola Trotta; Rita Murri; Patrizio De Longis; Crescenzo Izzo; Alfredo Scalzini; Antonella d'Arminio Monforte; Albert W Wu; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

9.  A prospective study of predictors of adherence to combination antiretroviral medication.

Authors:  Carol E Golin; Honghu Liu; Ron D Hays; Loren G Miller; C Keith Beck; Jeanette Ickovics; Andrew H Kaplan; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

10.  Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.

Authors:  Bruno Spire; Ségolène Duran; Marc Souville; Catherine Leport; François Raffi; Jean-Paul Moatti
Journal:  Soc Sci Med       Date:  2002-05       Impact factor: 4.634

View more
  51 in total

1.  Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.

Authors:  Andrew J Levine; Susan Service; Eric N Miller; Sandra M Reynolds; Elyse J Singer; Paul Shapshak; Eileen M Martin; Ned Sacktor; James T Becker; Lisa P Jacobson; Paul Thompson; Nelson Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-24       Impact factor: 3.568

2.  Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity.

Authors:  Stephanie A Sassoon; Margaret J Rosenbloom; Rosemary Fama; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychiatry Res       Date:  2012-05-29       Impact factor: 3.222

3.  Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy.

Authors:  V A Cardenas; D J Meyerhoff; C Studholme; J Kornak; J Rothlind; H Lampiris; J Neuhaus; R M Grant; L L Chao; D Truran; M W Weiner
Journal:  J Neurovirol       Date:  2009-07       Impact factor: 2.643

4.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

5.  Effects of Recent Alcohol Consumption Level on Neurocognitive Performance in HIV+ Individuals.

Authors:  Kara R Douglas-Newman; Rachel V Smith; Mary V Spiers; Timothy Pond; Henry R Kranzler
Journal:  Addict Disord Their Treat       Date:  2017-09

Review 6.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

Review 7.  Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Authors:  Lisa R Norman; Michael Basso; Anil Kumar; Robert Malow
Journal:  Curr Drug Abuse Rev       Date:  2009-05

8.  Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology.

Authors:  Timothy C Durazzo; Johannes C Rothlind; Valerie A Cardenas; Colin Studholme; Michael W Weiner; Dieter J Meyerhoff
Journal:  Alcohol       Date:  2007-10-17       Impact factor: 2.405

9.  Impairments in Component Processes of Executive Function and Episodic Memory in Alcoholism, HIV Infection, and HIV Infection with Alcoholism Comorbidity.

Authors:  Rosemary Fama; Edith V Sullivan; Stephanie A Sassoon; Adolf Pfefferbaum; Natalie M Zahr
Journal:  Alcohol Clin Exp Res       Date:  2016-10-19       Impact factor: 3.455

Review 10.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.